{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:02:36Z","timestamp":1756339356637,"version":"3.44.0"},"posted":{"date-parts":[[2025,8,27]]},"group-title":"In Review","reference-count":69,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA007927; P30DA033934; P30CA016059"],"award-info":[{"award-number":["T32DA007927; P30DA033934; P30CA016059"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,8,22]]},"abstract":"<title>Abstract<\/title>\n        <p>Chemotherapy-induced gastrointestinal toxicity is a significant dose-limiting complication for cancer treatment. Disruption of the gastrointestinal (GI) epithelial barrier function by several chemotherapeutic agents results in development of mucositis and diarrhea. Thus, maintaining barrier integrity may be of therapeutic benefit. Recent studies have shown the beneficial effects of the microbial metabolite butyrate, a short chain fatty acid (SCFA), on epithelial barrier integrity. In this current study, we tested the effect of oral butyrate on irinotecan-induced gastrointestinal (GI) toxicity in mice. Irinotecan dose-dependently reduced body weight and increased fecal water content. Nicotine-induced inward currents in ileum myenteric neurons were significantly increased in irinotecan treated mice consistent with enhanced GI motility. Loperamide reduced GI motility of irinotecan treated mice, however tolerance developed with chronic use, consistent with clinical findings of loperamide refractory diarrhea in patients. Oral butyrate improved epithelial permeability, prevented loss in stem cell marker, <italic>lgr5<\/italic> in colonic crypts and <italic>muc2<\/italic> expression in ileum. Butyrate also prevented irinotecan-induced increase in \u03b2-glucuronidase activity in fecal samples. Irinotecan treatment produced a significant shift in the \u03b2 diversity of the fecal microbiome that was mitigated by butyrate. The microbial dysbiosis was associated with increases in the mucin degrading bacteria <italic>Akkermansia muciniphilia<\/italic> and the hydrogen sulfide producing <italic>Desulfovibrio sp10575755<\/italic> that was reduced with butyrate treatment.<\/p>","DOI":"10.21203\/rs.3.rs-7436690\/v1","type":"posted-content","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:45:04Z","timestamp":1756280704000},"source":"Crossref","is-referenced-by-count":0,"title":["Butyrate Modulates Intestinal Microbiome and Epithelial Function to Attenuate Irinotecan-induced GI Toxicity"],"prefix":"10.21203","author":[{"given":"Stanley","family":"Cheatham","sequence":"first","affiliation":[{"name":"Virginia Commonwealth University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zayd","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahshid","family":"Arastonejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Kane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeem","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Luffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuesheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Tyc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Gewirtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1423-0774","authenticated-orcid":false,"given":"Hamid I","family":"Akbarali","sequence":"additional","affiliation":[{"name":"Virginia Commonwealth University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/1758834009355164","article-title":"Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management","volume":"2","author":"Stein A","year":"2010","unstructured":"Stein A, Voigt W, Jordan K (2010) Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. Ther Adv Med Oncol 2:51\u201363","journal-title":"Ther Adv Med Oncol"},{"key":"ref2","article-title":"Chemotherapy induced gastrointestinal toxicities","volume":"155","author":"Akbarali HI","year":"2022","unstructured":"Akbarali HI, Muchhala KH, Jessup DK, Cheatham S (2022) Chemotherapy induced gastrointestinal toxicities. in Adv Cancer Res 155","journal-title":"Adv Cancer Res"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.1998.16.8.2745","article-title":"Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: A prospective assessment","volume":"16","author":"Saliba F","year":"1998","unstructured":"Saliba F et al (1998) Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: A prospective assessment. J Clin Oncol 16","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1758834009355164","article-title":"Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management","author":"Stein A","unstructured":"Stein A, Voigt W, Jordan K Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management. 10.1177\/1758834009355164"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/86.6.446","article-title":"Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea","volume":"86","author":"Abigerges D","year":"1994","unstructured":"Abigerges D et al (1994) Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea. J Natl Cancer Inst 86","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1023\/A:1008372228462","article-title":"Octreotide in the treatment of severe chemotherapy-induced diarrhea","volume":"12","author":"Zidan J","year":"2001","unstructured":"Zidan J et al (2001) Octreotide in the treatment of severe chemotherapy-induced diarrhea. Ann Oncol 12","journal-title":"Ann Oncol"},{"key":"ref7","article-title":"Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma","volume":"71","author":"Topkan E","year":"2007","unstructured":"Topkan E, Karaoglu A (2007) Octreotide in the management of chemoradiotherapy-induced diarrhea refractory to loperamide in patients with rectal carcinoma. Oncology 71","journal-title":"Oncology"},{"key":"ref8","article-title":"Effective Management and Prevention of Neratinib-Induced Diarrhea","volume":"11","author":"Ustaris F","year":"2015","unstructured":"Ustaris F et al (2015) Effective Management and Prevention of Neratinib-Induced Diarrhea. Am J Hematol \/ Oncology\u00ae 11","journal-title":"Am J Hematol \/ Oncology\u00ae"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1200\/JCO.2004.04.132","article-title":"Recommended guidelines for the treatment of cancer treatment-induced diarrhea","volume":"22","author":"III ABB","year":"2004","unstructured":"III ABB et al (2004) Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol 22:2918\u20132926","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.3747\/co.2007.96","article-title":"Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: A consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea","volume":"14","author":"Maroun JA","year":"2007","unstructured":"Maroun JA et al (2007) Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: A consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea. Curr Oncol 14","journal-title":"Curr Oncol"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.121.000476","article-title":"Quantitative investigation of irinotecan metabolism, transport, and gut microbiome activation","volume":"49","author":"Parvez MM","year":"2021","unstructured":"Parvez MM et al (2021) Quantitative investigation of irinotecan metabolism, transport, and gut microbiome activation. Drug Metab Dispos 49","journal-title":"Drug Metab Dispos"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.3181\/0810-RM-301","article-title":"Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis","volume":"234","author":"Stringer AM","year":"2009","unstructured":"Stringer AM et al (2009) Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis. Exp Biol Med 234","journal-title":"Exp Biol Med"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00391","article-title":"irinotecan-induced gastrointestinal dysfunction is associated with enteric neuropathy, but increased numbers of cholinergic myenteric neurons","volume":"8","author":"McQuade RM","year":"2017","unstructured":"McQuade RM et al (2017) irinotecan-induced gastrointestinal dysfunction is associated with enteric neuropathy, but increased numbers of cholinergic myenteric neurons. Front Physiol 8","journal-title":"Front Physiol"},{"key":"ref14","article-title":"Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy","volume":"8","author":"Geng HW","year":"2021","unstructured":"Geng HW, Yin FY, Zhang ZF, Gong X, Yang Y (2021) Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy. Front Mol Biosci 8","journal-title":"Front Mol Biosci"},{"key":"ref15","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101598","article-title":"Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer","volume":"27","author":"Shuwen H","year":"2023","unstructured":"Shuwen H et al (2023) Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancer. Transl Oncol 27","journal-title":"Transl Oncol"},{"key":"ref16","article-title":"Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function","volume":"77","author":"Kleuskens MTA","year":"2022","unstructured":"Kleuskens MTA et al (2022) Butyrate and propionate restore interleukin 13-compromised esophageal epithelial barrier function. Allergy: Eur J Allergy Clin Immunol 77","journal-title":"Allergy: Eur J Allergy Clin Immunol"},{"key":"ref17","article-title":"Butyrate alleviates cytokine-induced barrier dysfunction by modifying claudin-2 levels","volume":"10","author":"Huang X","year":"2021","unstructured":"Huang X, Oshima T, Tomita T, Fukui H, Miwa H (2021) Butyrate alleviates cytokine-induced barrier dysfunction by modifying claudin-2 levels. Biology (Basel) 10","journal-title":"Biology (Basel)"},{"key":"ref18","first-page":"359","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","author":"Routy B","year":"2018","unstructured":"Routy B et al (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Sci (1979) 359","journal-title":"Sci (1979)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.10.018","author":"Chrysostomou D","year":"2023","unstructured":"Chrysostomou D, Roberts LA, Marchesi JR, Kinross JM (2023) Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy. Gastroenterology vol. 164 Preprint at https:\/\/doi.org\/10.1053\/j.gastro.2022.10.018"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13111166","author":"Hou Y","year":"2023","unstructured":"Hou Y, Li J, Ying S (2023) Tryptophan Metabolism and Gut Microbiota: A Novel Regulatory Axis Integrating the Microbiome, Immunity, and Cancer. Metabolites vol. 13 Preprint at https:\/\/doi.org\/10.3390\/metabo13111166"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2014.07.027","author":"O\u2019Mahony SM","year":"2015","unstructured":"O\u2019Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF (2015) Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research vol. 277 Preprint at https:\/\/doi.org\/10.1016\/j.bbr.2014.07.027"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-34678-z","article-title":"\u03b2-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut","volume":"8","author":"Dashnyam P","year":"2018","unstructured":"Dashnyam P et al (2018) \u03b2-Glucuronidases of opportunistic bacteria are the major contributors to xenobiotic-induced toxicity in the gut. Sci Rep 8","journal-title":"Sci Rep"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00280-016-3139-y","article-title":"Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives","volume":"78","author":"Ribeiro RA","year":"2016","unstructured":"Ribeiro RA et al (2016) Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives. Cancer Chemother Pharmacol 78:881\u2013893","journal-title":"Cancer Chemother Pharmacol"},{"key":"ref24","article-title":"Total Flavonoids of Glycyrrhiza uralensis Alleviates Irinotecan-Induced Colitis via Modification of Gut Microbiota and Fecal Metabolism","volume":"12","author":"Yue SJ","year":"2021","unstructured":"Yue SJ et al (2021) Total Flavonoids of Glycyrrhiza uralensis Alleviates Irinotecan-Induced Colitis via Modification of Gut Microbiota and Fecal Metabolism. Front Immunol 12","journal-title":"Front Immunol"},{"key":"ref25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2015.03.040","article-title":"Flavonoids derived from liquorice suppress murine macrophage activation by up-regulating heme oxygenase-1 independent of Nrf2 activation","volume":"28","author":"Wang R","year":"2015","unstructured":"Wang R et al (2015) Flavonoids derived from liquorice suppress murine macrophage activation by up-regulating heme oxygenase-1 independent of Nrf2 activation. Int Immunopharmacol 28","journal-title":"Int Immunopharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/jnci\/87.24.1876","article-title":"Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum","volume":"87","author":"Ikuno N","year":"1995","unstructured":"Ikuno N, Soda H, Watanabe M, Oka M (1995) Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. JNCI: J Natl Cancer Inst 87:1876\u20131883","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/jnci\/87.24.1876","article-title":"Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum","volume":"87","author":"Ikuno N","year":"1995","unstructured":"Ikuno N, Soda H, Watanabe M, Oka M (1995) Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. JNCI: J Natl Cancer Inst 87:1876\u20131883","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2013.124","article-title":"IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice","volume":"7","author":"Guabiraba R","year":"2014","unstructured":"Guabiraba R et al (2014) IL-33 targeting attenuates intestinal mucositis and enhances effective tumor chemotherapy in mice. Mucosal Immunol 7","journal-title":"Mucosal Immunol"},{"key":"ref29","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2023.1281698","article-title":"Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice","volume":"4","author":"Negus SS","year":"2023","unstructured":"Negus SS et al (2023) Role of mu opioid receptor (MOR) agonist efficacy as a determinant of opioid antinociception in a novel assay of pain-depressed behavior in female and male mice. Front Pain Res 4","journal-title":"Front Pain Res"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1038\/srep31203","article-title":"HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system","volume":"6","author":"Guedia J","year":"2016","unstructured":"Guedia J et al (2016) HIV-1 Tat exacerbates lipopolysaccharide-induced cytokine release via TLR4 signaling in the enteric nervous system. Sci Rep 6","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e23603","DOI":"10.1096\/fj.202301590RR","article-title":"The role of morphine-and fentanyl\u2010induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota\u2010gut\u2010brain axis","volume":"38","author":"Muchhala KH","year":"2024","unstructured":"Muchhala KH et al (2024) The role of morphine-and fentanyl\u2010induced impairment of intestinal epithelial antibacterial activity in dysbiosis and its impact on the microbiota\u2010gut\u2010brain axis. FASEB J 38:e23603","journal-title":"FASEB J"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/srep42658","article-title":"The effect of gut microbiome on tolerance to morphine mediated antinociception in mice","author":"Kang M","year":"2017","unstructured":"Kang M et al (2017) The effect of gut microbiome on tolerance to morphine mediated antinociception in mice. Sci Rep. 10.1038\/srep42658","journal-title":"Sci Rep"},{"key":"ref33","article-title":"I. An in-vitro preparation of isolated enteric neurons and glia from the myenteric plexus of the adult mouse","author":"Smith TH","year":"2013","unstructured":"Smith TH, Ngwainmbi J, Grider JR, Dewey WL, Akbarali H (2013) I. An in-vitro preparation of isolated enteric neurons and glia from the myenteric plexus of the adult mouse. J Vis Exp","journal-title":"J Vis Exp"},{"key":"ref34","author":"Smith TH","year":"2012","unstructured":"Smith TH, Grider JR, Dewey WL, Akbarali H (2012) I. Morphine decreases enteric neuron excitability via inhibition of sodium channels"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/jpet.116.233304","article-title":"Enhanced Sensitivity of \u03b13\u03b24 Nicotinic Receptors in Enteric Neurons after Long-Term Morphine: Implication for Opioid-Induced Constipation","volume":"357","author":"Gade AR","year":"2016","unstructured":"Gade AR et al (2016) Enhanced Sensitivity of \u03b13\u03b24 Nicotinic Receptors in Enteric Neurons after Long-Term Morphine: Implication for Opioid-Induced Constipation. J Pharmacol Exp Ther 357:520\u2013528","journal-title":"J Pharmacol Exp Ther"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.1203\/01.pdr.0000250014.92242.f3","article-title":"Effects of butyrate on intestinal barrier function in a caco-2 cell monolayer model of intestinal barrier","volume":"61","author":"Peng L","year":"2007","unstructured":"Peng L, He Z, Chen W, Holzman IR, Lin J (2007) Effects of butyrate on intestinal barrier function in a caco-2 cell monolayer model of intestinal barrier. Pediatr Res 61","journal-title":"Pediatr Res"},{"key":"ref37","author":"Korsten SGPJ","year":"2023","unstructured":"Korsten SGPJ, Vromans H, Garssen J, Willemsen LEM (2023) Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2\/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption. Nutrients 15"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101499","author":"Knudsen KEB","year":"2018","unstructured":"Knudsen KEB et al (2018) Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients vol. 10 Preprint at https:\/\/doi.org\/10.3390\/nu10101499"},{"key":"ref39","author":"Yu H","year":"2011","unstructured":"Yu H, Wu LH, Xu ZL, Dong D, He SA (2011) Protective effect of anthocyanins extract from blueberry on TNBS-induced IBD model of mice. Evidence-based Complementary and Alternative Medicine (2011)"},{"key":"ref40","article-title":"Analysis of spatiotemporal pattern and quantification of gastrointestinal slow waves caused by anticholinergic drugs","volume":"13","author":"Wong KKL","year":"2017","unstructured":"Wong KKL, Tang LCY, Zhou J, Ho V (2017) Analysis of spatiotemporal pattern and quantification of gastrointestinal slow waves caused by anticholinergic drugs. Organogenesis 13","journal-title":"Organogenesis"},{"key":"ref41","article-title":"I. An in-vitro preparation of isolated enteric neurons and glia from the myenteric plexus of the adult mouse","author":"Smith TH","year":"2013","unstructured":"Smith TH, Ngwainmbi J, Grider JR, Dewey WL, Akbarali H (2013) I. An in-vitro preparation of isolated enteric neurons and glia from the myenteric plexus of the adult mouse. J Vis Exp","journal-title":"J Vis Exp"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/jpet.116.233304","article-title":"Enhanced Sensitivity of \u03b13\u03b24 Nicotinic Receptors in Enteric Neurons after Long-Term Morphine: Implication for Opioid-Induced Constipation","volume":"357","author":"Gade AR","year":"2016","unstructured":"Gade AR et al (2016) Enhanced Sensitivity of \u03b13\u03b24 Nicotinic Receptors in Enteric Neurons after Long-Term Morphine: Implication for Opioid-Induced Constipation. J Pharmacol Exp Ther 357:520\u2013528","journal-title":"J Pharmacol Exp Ther"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3791\/56960","article-title":"B. Real-time measurement of epithelial barrier permeability in human intestinal organoids","author":"Hill DR","year":"2017","unstructured":"Hill DR, Huang S, Tsai YH, Spence JR, Young V (2017) B. Real-time measurement of epithelial barrier permeability in human intestinal organoids. J Visualized Experiments. 10.3791\/56960","journal-title":"J Visualized Experiments"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44857-2","article-title":"I. Short-chain fatty acid, butyrate prevents morphine-and paclitaxel-induced nociceptive hypersensitivity","volume":"13","author":"Jessup D","year":"2023","unstructured":"Jessup D, Woods K, Thakker S, Damaj MI, Akbarali H (2023) I. Short-chain fatty acid, butyrate prevents morphine-and paclitaxel-induced nociceptive hypersensitivity. Sci Rep 13","journal-title":"Sci Rep"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.03.002","author":"Chamseddine AN","year":"2019","unstructured":"Chamseddine AN et al (2019) Intestinal bacterial \u03b2-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity. Pharmacology and Therapeutics vol. 199 Preprint at https:\/\/doi.org\/10.1016\/j.pharmthera.2019.03.002"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1073\/pnas.1918095117","article-title":"Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy","volume":"117","author":"Bhatt AP","year":"2020","unstructured":"Bhatt AP et al (2020) Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy. Proc Natl Acad Sci U S A 117:7374\u20137381","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref47","article-title":"Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt","volume":"398","author":"Sun R","year":"2020","unstructured":"Sun R et al (2020) Irinotecan-mediated diarrhea is mainly correlated with intestinal exposure to SN-38: Critical role of gut Ugt. Toxicol Appl Pharmacol 398","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2016.02.005","author":"Derrien M","year":"2017","unstructured":"Derrien M, Belzer C, de Vos WM (2017) Akkermansia muciniphila and its role in regulating host functions. Microbial Pathogenesis vol. 106 Preprint at https:\/\/doi.org\/10.1016\/j.micpath.2016.02.005"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2016.02.005","author":"Derrien M","year":"2017","unstructured":"Derrien M, Belzer C, de Vos WM (2017) Akkermansia muciniphila and its role in regulating host functions. Microbial Pathogenesis vol. 106 Preprint at https:\/\/doi.org\/10.1016\/j.micpath.2016.02.005"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1089600","author":"Zheng M","year":"2023","unstructured":"Zheng M et al (2023) The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives. Frontiers in Immunology vol. 13 Preprint at https:\/\/doi.org\/10.3389\/fimmu.2022.1089600"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.934695","author":"Rodrigues VF","year":"2022","unstructured":"Rodrigues VF et al (2022) Akkermansia muciniphila and Gut Immune System: A Good Friendship That Attenuates Inflammatory Bowel Disease, Obesity, and Diabetes. Frontiers in Immunology vol. 13 Preprint at https:\/\/doi.org\/10.3389\/fimmu.2022.934695"},{"key":"ref52","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The Warburg Effect Dictates the Mechanism of Butyrate-Mediated Histone Acetylation and Cell Proliferation","volume":"48","author":"Donohoe DR","year":"2012","unstructured":"Donohoe DR et al (2012) The Warburg Effect Dictates the Mechanism of Butyrate-Mediated Histone Acetylation and Cell Proliferation. Mol Cell 48","journal-title":"Mol Cell"},{"key":"ref53","article-title":"K. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer","volume":"18","author":"Gibson RJ","year":"2003","unstructured":"Gibson RJ, Bowen JM, Inglis MRB, Cummins AG, Keefe DM (2003) K. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J Gastroenterol Hepatol (Australia) 18","journal-title":"J Gastroenterol Hepatol (Australia)"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.proghi.2009.10.001","author":"Harrington AM","year":"2010","unstructured":"Harrington AM, Hutson JM, Southwell BR (2010) Cholinergic neurotransmission and muscarinic receptors in the enteric nervous system. Progress in Histochemistry and Cytochemistry vol. 44 Preprint at https:\/\/doi.org\/10.1016\/j.proghi.2009.10.001"},{"key":"ref55","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2011.01702.x","article-title":"The relationship between inflammation-induced neuronal excitability and disrupted motor activity in the guinea pig distal colon","volume":"23","author":"Hoffman JM","year":"2011","unstructured":"Hoffman JM, Mcknight ND, Sharkey KA, Mawe GM (2011) The relationship between inflammation-induced neuronal excitability and disrupted motor activity in the guinea pig distal colon. Neurogastroenterol Motil 23","journal-title":"Neurogastroenterol Motil"},{"key":"ref56","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2017.00391","article-title":"irinotecan-induced gastrointestinal dysfunction is associated with enteric neuropathy, but increased numbers of cholinergic myenteric neurons","volume":"8","author":"McQuade RM","year":"2017","unstructured":"McQuade RM et al (2017) irinotecan-induced gastrointestinal dysfunction is associated with enteric neuropathy, but increased numbers of cholinergic myenteric neurons. Front Physiol 8","journal-title":"Front Physiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1124\/jpet.119.256941","article-title":"Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine via Peripheral Opioid Receptors","volume":"370","author":"Komla E","year":"2019","unstructured":"Komla E et al (2019) Experimental Colitis Enhances the Rate of Antinociceptive Tolerance to Morphine via Peripheral Opioid Receptors. J Pharmacol Exp Ther 370:504\u2013513","journal-title":"J Pharmacol Exp Ther"},{"key":"ref58","doi-asserted-by":"crossref","DOI":"10.1111\/bph.16020","article-title":"Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model","volume":"180","author":"Meng J","year":"2023","unstructured":"Meng J et al (2023) Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model. Br J Pharmacol 180","journal-title":"Br J Pharmacol"},{"key":"ref59","doi-asserted-by":"crossref","DOI":"10.4161\/cbt.7.12.6940","article-title":"Faecal microflora and \u03b2-glucuronidase expression are altered in an irinotecan-induced diarrhoea model in rats","volume":"7","author":"Stringer AM","year":"2008","unstructured":"Stringer AM et al (2008) Faecal microflora and \u03b2-glucuronidase expression are altered in an irinotecan-induced diarrhoea model in rats. Cancer Biol Ther 7","journal-title":"Cancer Biol Ther"},{"key":"ref60","doi-asserted-by":"crossref","DOI":"10.4161\/cbt.7.12.6940","article-title":"Faecal microflora and \u03b2-glucuronidase expression are altered in an irinotecan-induced diarrhoea model in rats","volume":"7","author":"Stringer AM","year":"2008","unstructured":"Stringer AM et al (2008) Faecal microflora and \u03b2-glucuronidase expression are altered in an irinotecan-induced diarrhoea model in rats. Cancer Biol Ther 7","journal-title":"Cancer Biol Ther"},{"key":"ref61","article-title":"Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial \u03b2-glucuronidase","volume":"12","author":"Yue B","year":"2021","unstructured":"Yue B et al (2021) Berberine Improves Irinotecan-Induced Intestinal Mucositis Without Impairing the Anti-colorectal Cancer Efficacy of Irinotecan by Inhibiting Bacterial \u03b2-glucuronidase. Front Pharmacol 12","journal-title":"Front Pharmacol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1126\/science.1191175","article-title":"Alleviating cancer drug toxicity by inhibiting a bacterial enzyme","volume":"330","author":"Wallace BD","year":"2010","unstructured":"Wallace BD et al (2010) Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 330:831\u2013835","journal-title":"Science"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1073\/pnas.1918095117","article-title":"Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy","volume":"117","author":"Bhatt AP","year":"2020","unstructured":"Bhatt AP et al (2020) Targeted inhibition of gut bacterial \u03b2-glucuronidase activity enhances anticancer drug efficacy. Proc Natl Acad Sci U S A 117:7374\u20137381","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref64","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2019.02259","article-title":"Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice","volume":"10","author":"Bian X","year":"2019","unstructured":"Bian X et al (2019) Administration of Akkermansia muciniphila Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice. Front Microbiol 10","journal-title":"Front Microbiol"},{"key":"ref65","article-title":"Strain-specific effects of Akkermansia muciniphila on the regulation of intestinal barrier","volume":"12","author":"Liu Y","year":"2023","unstructured":"Liu Y et al (2023) Strain-specific effects of Akkermansia muciniphila on the regulation of intestinal barrier. Food Sci Hum Wellness 12","journal-title":"Food Sci Hum Wellness"},{"key":"ref66","author":"Nie Y","year":"2023","unstructured":"Nie Y et al (2023) Desulfovibrio fairfieldensis-Derived Outer Membrane Vesicles Damage Epithelial Barrier and Induce Inflammation and Pyroptosis in Macrophages. Cells 12"},{"key":"ref67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135280","article-title":"A preliminary study examining the binding capacity of Akkermansia muciniphila and Desulfovibrio spp., to colonic mucin in health and ulcerative colitis","volume":"10","author":"Earley H","year":"2015","unstructured":"Earley H et al (2015) A preliminary study examining the binding capacity of Akkermansia muciniphila and Desulfovibrio spp., to colonic mucin in health and ulcerative colitis. PLoS ONE 10","journal-title":"PLoS ONE"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13099-024-00632-w","article-title":"Desulfovibrio vulgaris caused gut inflammation and aggravated DSS-induced colitis in C57BL\/6 mice model","volume":"16","author":"Huang G","year":"2024","unstructured":"Huang G et al (2024) Desulfovibrio vulgaris caused gut inflammation and aggravated DSS-induced colitis in C57BL\/6 mice model. Gut Pathog 16:39","journal-title":"Gut Pathog"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1093\/advances\/nmx009","author":"Liu H","year":"2018","unstructured":"Liu H et al (2018) Butyrate: A double-edged sword for health? Advances in Nutrition vol. 9 Preprint at https:\/\/doi.org\/10.1093\/advances\/nmx009"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7436690\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7436690\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:45:15Z","timestamp":1756280715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7436690\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":69,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7436690\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,8,27]]},"subtype":"preprint"}}